Cannabis
Drug Plants Vs Manufactured Products: What’s Better?
When it comes to plant drugs, you often have the option of the plant, or manufactured products. Which is better? Read on…
Plant drugs
Not every drug is a plant. Though some like LSD and MDMA are based on plants or are synthesized using plants (ergot fungus and sassafras, respectively), some popular drugs, are nothing but a plant. Think of weed. We call it by this word because it’s literally a weed that grows by roadsides in many places. It doesn’t require any preparation beyond heating it; and plenty is gained without heat at all. Magic mushrooms are another great example of a basic plant drug that can be pulled from the ground and ingested, with no further preparation.
Beyond this, we have a range of drugs that started as natural, but were then processed into something stronger. Like heroin. Heroin is morphine processed with ascetic acid. Or cocaine, a processed form of coca leaves that involves nitric acid. In these cases there’s a certain amount of processing that goes on, but its done around the basis of the original plant. However, due to the processing; the results are a much more intense product. Cocaine is even processed further to make crack, a more intense version of cocaine.
Plant drugs have been used for thousands of years, long past recorded history. Some of what we know comes from fossilized findings, and carbon dated remnants. In terms of recorded history, from medical books to scripture; plants factor in as far as recordings go back. Different locations of the world worked with what they each had available. And they often came to the exact same understandings of a plant, in differing periods and locations; for which there would have been no communication or ways to share ideas.
Plants were (and are) widely used for spiritual purposes by many indigenous tribes the world over; as well as for medical treatments, and recreational use. Sometimes they are used so much, and so entrenched in culture; that modern governments allow them. Peyote is a great example. It’s used so widely by native cultures in the US, the federal government finally legalized the plant for spiritual use; a law that applies to anyone who wants to use the plant for this purpose, even beyond native tribes.
Synthetic drugs
The other side in plants vs manufactured products, is the manufactured products. These fall into two categories in my mind: products that are made from a plant, but produced in a different form; or completely synthesized, lab-made drugs. In either case, these products don’t grow directly out of the ground.
When it comes to products made from the plant, without creating a new drug; one of the best examples is vape products for cannabis and tobacco. And by this I specifically mean oil vapes, since dry herb vapes don’t require any level of production for the weed used. Oil vapes are vapes that use oil cartridges, and these cartridges contain compounds from the plants, that are leached into the oil. Instead of dealing with the plant, the user just deals with an oil cartridge and a battery.
Edible products are also included here. A brownie is not directly weed, and a gummy is not directly a mushroom. The drugs must be processed to some degree to create an edible form. This is something the average person can do in their kitchen with the right setup; but something for which there is a large and growing sales market, as well. Whereas you can choose what to put in when cooking at home; store-bought products include whatever ingredients the given company chose for their recipe.
When it comes to synthesized lab-made drugs, some examples are drugs like LSD, MDMA, antidepressants, synthetic opioids, Tylenol, and methamphetamine. There is no original form of any of these, so the only way they exist, is as lab-made products. Whether they’re synthesized using a plant is not important; as the drugs themselves are too different from the plants that they’re made from, to be associated with them in terms of effects.
Plants vs manufactured products – when manufactured is better
Some drugs only exist as one or the other. There is no natural form of methamphetamine, but there is also no lab-made version of salvia. Others exist in both realms. You can eat amanita mushrooms, or buy the gummy version; and same with cannabis. Both of these plants, and their accompanying industries, are great examples of the difference between plants and manufactured products.
Which is better? This is a matter of opinion. When it comes to weed, some manufactured products, like vapes, provide a more intense high than the plant itself; because they’re a more concentrated version. This is a useful concept for medicating; when often a very strong version of something is needed to get a medical effect. The weed industry provides both options, plants and manufactured products; and either can be decent in terms of effects, with manufactured products often offering a more intense experience.
Amanita mushrooms are another plant drug that has a good reason for manufacturing. These mushrooms come with a main compound that can make a person sick; though not enough to die. This compound, ibotenic acid, can be processed out through the decarboxylation method of boiling. This can be done by the individual who wants to use them; or by manufacturers who produce gummies or other edible products. In the latter case, all the user must do, is eat the product.
Manufactured products also come with the upside of dosing. We don’t all want or need the same amount, but its hard to know how much of the active compounds (or dangerous compounds) we’re taking in, when consuming plant material. Manufactured products generally have measured levels of compounds, creating a consistent experience; and making it easier for those who are less familiar with something, to get it right. This idea of consistency promotes the API market for pharmaceuticals.
Plants vs manufactured products – when plants are better
There are some issues, however, with manufactured products. Just like they can sometimes be more potent than their plant counterparts, sometimes it’s the opposite. Amanita mushrooms are once again a an applicable example. They’re newer to American culture, and don’t have a history of use as a plant. But they’re also hallucinogenic mushrooms (though different from psilocybin, as they work mainly off the compound muscimol). Producers seem generally afraid to create products with full-blown effects, which creates a market of products that don’t do much, even though the mushrooms themselves, do.
In terms of products being too strong, this is also an issue. A newer rise in emergency room visits is connected with very high THC products, which have become the norm. Whereas plants don’t generally have more than 20% THC (although this amount is incredibly inflated from earlier decades), manufactured products boast numbers like 90% THC. This is no longer in the standard realm of today; and its not shocking that more people get sick. Luckily, THC overdoses are not deadly, just uncomfortable.
Another issue is companies adding toxic substances. Not only does weed not need a lot of pesticides or other chemicals, it wasn’t an industry associated with them as a black market. Yet now with mass legal production, we’re suddenly dealing with sprayed weed, and overuse of agricultural chemicals. What once was a clean black market, is now a grossly dirty legal market; yet its the legal market that always brags about testing. Even though those tests back up just how dirty legal production is.
And then think about vapes. Weed might be sprayed with chemicals, but it doesn’t have to be. A vape cart doesn’t exist without the addition of some chemicals. Some are used that don’t have to be, like flavoring or colorants. But other things are necessary since its not a standard state for weed to be in, and it has to be preserved for transport. As such, things like stabilizers and preservatives (vitamin e-acetate) come into play. And this is beyond whatever other tinkering a manufacturer might do.
The same can be said for gummies, and other edibles. The US food market is not a pretty place, because regulation allows for tons of dangerous chemicals in food production. Sure, its possible to make a clean cannabis or mushroom edible, just like its possible to grow organic vegetables, or produce clean meat. However, just because something can happen, doesn’t mean it will. Edibles are food products; and liable to have a list of chemical ingredients, that only people with high level science degrees can pronounce.
Final thoughts
The reality is that for some drugs, both a plant option and a manufactured option, exist. It comes down to a buyer’s personal decision as to what is better. If you want the most basic, unadulterated form; the plant is best. But if you need a stronger product, want the convenience of vapes or edibles, need specific dosing, or have more trust in manufactured products; then this is probably the better option. Either way, if its well made/grown, you should definitely catch a buzz.
Hey all! Cool that you’re with us at Cannadelics.com; a news source in the independent realm, reporting on the most interesting stories in the growing cannabis and hallucinogen worlds. Hang out with us regularly to catch the updates; and get signed up to the Cannadelics Weekly Newsletter; so you’re always up on what’s going down.
Related
Tariffs are the word of the day – but marijuana consumers need to be ready to see a change also.
From apples to automobiles, hundreds of industries are trying to figure out the new tariffs. What is clear is prices are going up on a random amount of things. But, why is a surprise, is cannabis consumers are being hit by the tariffs also. Although cannabis itself cannot be imported or exported due to federal restrictions, the industry heavily relies on international suppliers for key components like vaporizer hardware, packaging, and cultivation equipment.
RELATED: Mixed Messages From The Feds About Cannabis
For instance, products sourced from China now face cumulative tariffs as high as 45%, including a 10% increase imposed in February 2025. Similarly, imports from Canada and Mexico face 25% tariffs. These measures have particularly affected items like vape cartridges, batteries, and specialized packaging materials, which are difficult to source domestically at competitive prices. As a result, many cannabis companies are passing these increased costs down the supply chain to consumer
The financial burden of these tariffs is substantial. Analysts estimate that most cannabis businesses lack the margin flexibility to absorb a 10%-15% cost increase. This has led to higher retail prices for products like pre-rolls and vaporizers, potentially pushing consumers toward cheaper, unregulated black-market alternatives. Such a shift raises concerns about product safety and could undermine the legal market’s growth.
Additionally, the tariffs have caused stock prices of major cannabis companies like Tilray Brands and Canopy Growth to decline by 5%-10%, reflecting investor concerns over profitability.Smaller businesses, already constrained by high taxes and limited banking access, are particularly vulnerable to these economic pressures.
Efforts to mitigate tariff-related expenses include exploring alternative manufacturing locations in countries like Malaysia or India. However, transitioning production is complex and time-consuming due to logistical hurdles and regulatory compliance requirements. Domestic production is another option but often comes with higher costs and limited capacity.
RELATED: How To Be Discreet When Using Weed
Packaging regulations in many states exacerbate the situation by requiring child-resistant designs, further limiting affordable domestic alternatives. Some companies are exploring sustainable packaging solutions as a long-term strategy to reduce dependence on volatile international markets.
The ongoing trade tensions show no signs of easing under Trump’s administration, leaving cannabis businesses with little choice but to adapt quickly. Strategies such as diversifying suppliers, investing in automation, and innovating with local materials may help companies weather the storm. However, without significant policy shifts or financial support mechanisms, the industry faces a challenging road ahead.
There is a buzz about sore throats today. While they are most common in colder months, spring allergies bring the pain also. This is often due to postnasal drip, which is when mucus from the nose and sinuses drains down the back of the throat, causing irritation and a scratchy feeling. Overuse of the voice, like talking loudly or singing for long periods, can tire out and strain the muscles in your throat, causing them to feel sore. The good news is cannabis can help a sore throat.
RELATED: How Hemp Helps You Sleep
For those seeking natural alternatives to manage cold symptoms, cannabis is emerging as a promising option for throat irritation. Increasing research at medical center specifically targeting sore throats shows early insights. The data suggests cannabinoids and terpenes could offer symptom relief through their unique properties.
Cannabis contains compounds like THC and CBD, which studies indicate possess anti-inflammatory properties that may reduce throat swelling and irritation. Terpenes such as eucalyptol—found in some strains—are traditionally associated with decongestant effects, potentially easing respiratory discomfort. These components work synergistically to calm inflamed tissues, though their direct impact on sore throats requires further clinical validation.
Smoking cannabis while ill remains controversial due to potential throat irritation from heat and smoke. Instead, experts recommend gentler options:
-
Edibles/lozenges: THC or CBD-infused products bypass inhalation, delivering localized relief without aggravating the throat.
-
Cannabis tea: Warm beverages with cannabis extracts may soothe scratchy throats while providing hydration.
-
Tinctures: Sublingual CBD oils allow precise dosing and avoid respiratory irritation.
Beyond direct throat relief, cannabis may improve overall wellness during illness. THC’s appetite-stimulating properties can combat reduced hunger, while its relaxing effects might promote restorative sleep. CBD’s muscle-relaxing qualities could help alleviate the body aches often accompanying colds.
RELATED: How To Stop Coughing So Hard From Marijuana Smoke
While preliminary findings are encouraging, users should consult healthcare providers before combining cannabis with conventional cold medications due to potential interactions. Starting with low-dose CBD products may offer benefits without psychoactive effects. As legalization expands, more targeted research is expected to clarify cannabis’s role in respiratory health.
Innovative cannabis formulations—from throat-calming lozenges to anti-inflammatory teas—are redefining how we approach minor ailments. For those navigating cold season, these plant-based solutions present a compelling fusion of traditional herbal wisdom and modern cannabinoid science
Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.
The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.
RELATED: Music Is A Turn On Like Sex And Marijuana
The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.
During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.
The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.
The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.
RELATED: The Science Behind Why Music Sounds So Much Better When You’re High
While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.
MJBizCon offers speakers chance to share cannabis insights, shape industry
The Best Tariff Friendly Cocktails
Cannabis Consumers Are Being Hit By The Tariffs
The Best Tips To Update Your Wardrobe
Former New York Knick Iman Shumpert debuts ‘TSA Approved’ legal cannabis brand
How New York pot pioneers made it to legal dispensary shelves
Scientists Now Think That One Compound in the Cannabis Plant Can Replace All Opiates
Vladimir Bautista is leading Happy Munkey’s legacy-to-legal takeover
Cannabis Can Help A Sore Throat
Cannabis and the Authoritarian State
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
-
Cannabis News2 years agoDistressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years agoUnited States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years agoWhat you Need to Know
-
drug testing1 year agoDrug Testing for Marijuana – The Joint Blog
-
Education2 years agoNCIA Write About Their Equity Scholarship Program
-
Cannabis2 years agoIt has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years agoCannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years agoA new April 20 cannabis contest includes a $40,000 purse